Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
For bodybuilders, athletes, or sportspeople, peptides like Ipamorelin are a game-changer due to their many health benefits, outlined below
Janumet can cause headaches in some people who take it
That's because coverage rules typically apply to all of the plan options through your job
Muscle recovery happens during sleep
Cardiovascular Diabetology, 18, 163 6